Buy & Sell Philip Morris International Inc. (PM) – Philip Morris International Inc. Price Today
Aura AI Summary
Key Stats
- $278.19BMarket Cap
- Consumer StaplesSector
- -12.32%3M Drawdown
- $324.69BEnterprise Value
- 3.29%Dividend Yield
- 36% Buy | 64% SellTrading Activity
- 80 daysTypical Hold Time
Philip Morris International Inc. (PM) is currently valued at a market capitalization of $278.19B, with an enterprise value of $324.69B. Over the past 52 weeks, Philip Morris International Inc. has traded between a low of $144.33 and a high of $191.86, highlighting its annual price range. Over the past three months, Philip Morris International Inc. has recorded a drawdown of -12.32%, reflecting recent price volatility. Philip Morris International Inc. offers a dividend yield of 3.29%, with the most recent dividend of $1.47 paid on 19 Mar 26. On average, investors hold Philip Morris International Inc. for approximately 80 days, indicating typical investor behavior on the platform.
About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Most Recent News
US government moves toward equity stakes in AI firms ahead of historic IPOs, reshaping investor ownership.
The US government is actively negotiating to take equity stakes in AI companies like OpenAI and Anthropic ahead of their planned IPOs, following a precedent set by its investment in Intel. This move aims to give the public a share in AI-driven growth...

Trulieve becomes first US cannabis stock listed on NYSE, signaling sector shift.
Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for m...

BIO-key flagged by Nasdaq for late 10-Q filing, risking its Nasdaq listing status.
BIO-key International, a leader in biometric authentication, received a Nasdaq notice for failing to file its quarterly 10-Q report on time for Q1 2026. Nasdaq's notice indicates the company's compliance with listing rules is under review, and a hear...
